RhumbLine Advisers’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-69,755
| Closed | -$60.1K | – | 4217 |
|
|
2025
Q1 | $60.1K | Sell |
69,755
-3,628
| -5% | -$3.12K | ﹤0.01% | 3533 |
|
|
2024
Q4 | $123K | Buy |
73,383
+2,497
| +4% | +$4.2K | ﹤0.01% | 3411 |
|
|
2024
Q3 | $202K | Sell |
70,886
-3,729
| -5% | -$10.6K | ﹤0.01% | 3236 |
|
|
2024
Q2 | $175K | Sell |
74,615
-243
| -0.3% | -$569 | ﹤0.01% | 3304 |
|
|
2024
Q1 | $220K | Buy |
74,858
+1,928
| +3% | +$5.67K | ﹤0.01% | 3132 |
|
|
2023
Q4 | $218K | Sell |
72,930
-1,195
| -2% | -$3.57K | ﹤0.01% | 3141 |
|
|
2023
Q3 | $234K | Buy |
74,125
+2,677
| +4% | +$8.46K | ﹤0.01% | 3073 |
|
|
2023
Q2 | $277K | Buy |
71,448
+668
| +0.9% | +$2.59K | ﹤0.01% | 3065 |
|
|
2023
Q1 | $196K | Buy |
70,780
+1,394
| +2% | +$3.86K | ﹤0.01% | 2740 |
|
|
2022
Q4 | $125K | Buy |
69,386
+392
| +0.6% | +$706 | ﹤0.01% | 2876 |
|
|
2022
Q3 | $146K | Buy |
68,994
+3,763
| +6% | +$7.96K | ﹤0.01% | 2953 |
|
|
2022
Q2 | $175K | Buy |
+65,231
| New | +$175K | ﹤0.01% | 2965 |
|